Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Immunology|August 1, 1987
Characterization of the human Goodpasture antigenJ Wieslander, M Kataja, B G Hudson
Scandinavian Journal of Urology and Nephrology|January 1, 1982
Clinical experience of long-term treatment with minoxidil in severe arterial hypertensionK E Hagstam, R Lundgren, J Wieslander
Kidney International|May 1, 1991
Circulating anti-entactin antibodies in patients with glomerulonephritisR Saxena, P Bygren, B Cederholm, et al.
Clinical and Experimental Immunology|September 1, 1996
Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptidesT Hellmark, C Brunmark, J Trojnar, et al.
Clinical and Experimental Immunology|April 1, 1997
Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?M Segelmark, B Persson, T Hellmark, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1985
A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint diseaseD Heinegård, S Inerot, J Wieslander, et al.
Annals of the Rheumatic Diseases|October 1, 1994
Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disordersR Saxena, G Sturfelt, O Nived, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Non-Goodpasture anti-GBM antibodies in patients with glomerulonephritisP Bygren, B Cederholm, D Heinegård, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IVB Cederholm, J Wieslander, P Bygren, et al.
Pageof 13